甘李药业股份有限公司2025年度权益分派实施公告详解
一、公告要点
- 分红比例：每股现金红利1元（含税），基于总股本597,304,969股，合计派发现金红利597,304,969元（含税）。
- 重要日期：
- 股权登记日：2026年5月28日
- 除权（息）日：2026年5月29日
- 现金红利发放日：2026年5月29日
- 差异化分红送转：无
- 分红方案已获股东大会审议通过：2026年5月13日
二、详细分红方案及实施办法
- 分派对象：截至股权登记日收市后在中国证券登记结算有限责任公司上海分公司登记在册的全体股东。
- 分红发放方式：
- 无限售条件流通股的红利通过中国结算上海分公司资金清算系统发放，已办理指定交易的投资者可在指定证券营业部领取现金红利。
- 未办理指定交易的股东红利暂由中国结算上海分公司保管，待办理后再派发。
- 甘忠如先生和北京旭特宏达科技有限公司的红利由公司自行发放。
- 税务处理：
- 自然人股东和证券投资基金：股息红利暂不扣税，实际派发1元。转让股票时，根据持股期限由证券公司等扣收并划付税款。
- QFII（合格境外机构投资者）股东：公司统一按10%税率代扣代缴企业所得税，税后每股实际派发0.90元。若需享受税收协定待遇，可自行申请。
- 沪港通投资者：同样按10%税率代扣代缴，税后每股实际派发0.90元。可自行申请退税。
- 其他机构投资者和法人股东：自行缴纳所得税，实际派发税前每股1元。
三、股权激励价格调整
本次权益分派实施完成后，公司股权激励相关价格将做相应调整，具体价格调整将在后续公告中披露。
四、投资者关心的重点和影响分析
- 高比例现金分红：每股1元，分红总额近6亿元，显示公司盈利能力强，对投资者具有较高吸引力，可能提振股价。
- 分红政策透明且及时：分红方案已获股东大会通过，实施细节清晰，有利于增强市场信心。
- 税务处理细致：不同类型股东的税务处理方式明确，有助于投资者合理安排税务。
- 股权激励价格调整：分红后激励价格调整，可能对员工激励和公司治理产生影响，需关注后续公告。
- 分红发放流程规范：资金清算与指定交易流程明确，保障红利及时发放。
五、其他信息
- 咨询方式：有疑问可联系公司证券部，电话：010-80593699。
六、投资风险提示
公司本次高比例现金分红可能提升吸引力，但投资者仍需关注公司未来业绩、行业环境以及分红后股权激励价格调整带来的潜在影响。
免责声明：本文内容仅供参考，不构成投资建议。投资者请根据自身情况审慎决策，关注公司公告及市场风险。
Gan & Lee Pharmaceuticals Co., Ltd. 2025 Annual Dividend Implementation Announcement – Detailed Analysis
Key Points of the Announcement
- Dividend Ratio: Cash dividend of RMB 1 per share (tax inclusive), based on total share capital of 597,304,969 shares, totaling RMB 597,304,969 (tax inclusive).
- Important Dates:
- Shareholder record date: May 28, 2026
- Ex-dividend date: May 29, 2026
- Cash dividend payment date: May 29, 2026
- No differentiated dividend or bonus share issues.
- Dividend plan approved by shareholders’ meeting: May 13, 2026
Detailed Dividend Plan and Implementation
- Eligible shareholders: All shareholders registered with China Securities Depository and Clearing Corporation Shanghai Branch at the close of trading on the record date.
- Dividend Distribution Method:
- Dividends for unrestricted tradable shares will be distributed through the clearing system at CSDC Shanghai Branch. Investors with designated transactions can collect their dividends at their designated securities branch.
- Dividends for shareholders without designated transactions will be temporarily held and distributed after designation is completed.
- Dividends for Mr. Gan Zhongru and Beijing Xute Hongda Technology Co., Ltd. will be distributed directly by the company.
- Tax Treatment:
- Individual shareholders and securities investment funds: No tax deduction at distribution, actual payment RMB 1 per share. Tax will be withheld upon transfer of shares, based on holding period.
- QFII shareholders: 10% enterprise income tax will be withheld, net dividend RMB 0.90 per share. Can apply for treaty benefits if eligible.
- Hong Kong Stock Exchange investors (via Stock Connect): 10% tax withheld, net dividend RMB 0.90 per share. Can apply for tax refund if eligible.
- Other institutional and corporate shareholders: Responsible for their own tax payments, pre-tax dividend RMB 1 per share.
Equity Incentive Price Adjustment
After the dividend distribution, the equity incentive prices will be adjusted accordingly. Further details will be disclosed in subsequent announcements.
Investor Focus & Potential Impact
- High cash dividend ratio: RMB 1 per share, total payout nearly RMB 600 million, signals strong financials, likely to boost investor sentiment and share price.
- Transparent and timely dividend policy: Plan approved, implementation details clear, supports investor confidence.
- Clear tax treatment: Different treatment for various shareholder types, helps investors optimize tax planning.
- Equity incentive price adjustment: May affect employee motivation and corporate governance; monitor future announcements.
- Normative dividend process: Clear distribution and transaction procedures ensure timely payment.
Other Information
- Contact for inquiries: Securities Department, phone: 010-80593699.
Risk Disclaimer
The high cash dividend may enhance the company’s attractiveness, but investors should pay attention to future earnings, industry trends, and potential effects of equity incentive price adjustments.
Disclaimer: This article is for information only and does not constitute investment advice. Please make prudent decisions based on your own circumstances and pay attention to company announcements and market risks.
